This website uses cookies to understand how you use the website and to improve your experience. By continuing to use the website, you accept the University of New England’s use of cookies and similar technologies. To learn more about our use of cookies and how to manage your browser cookie settings, please review our Privacy Notice.


UNE's Center for Excellence in the Neurosciences: A Catalyst for Education, Research and Economic Development

Seminar Center for Excellence in the Neurosciences Seminar Series

Edward Bilsky, Ph.D.

Professor of Pharmacology, COM, Director, CEN, University of New England


Dr. Edward Bilsky received his B.S. (physics) in 1989 and M.S. (Behavioral Neuroscience) in 1991 from Rensselaer Polytechnic Institute. He went on to earn a Ph.D. in Pharmacology and Toxicology from the University of Arizona Colleges of Medicine and Pharmacy in 1996. After completing a post-doctoral fellowship at the University of Arizona, he joined the faculty at the University of Northern Colorado in 1997. In 2001, he joined the faculty at the University of New England where he is currently a tenured Professor of Pharmacology and the Director of the Center of Excellence in Neuroscience. He lectures on a variety of topics to students in the colleges of Osteopathic Medicine, Health Professions and Arts and Sciences. Dr. Bilsky’s laboratory conducts translational research in the areas of pain, addiction and other neurological disorders. He has received over 4.8 million dollars in extramural funding through a variety of federal, state and private grants and contracts including the National Institutes of Health, the Office of Naval Research and biotechnology/pharmaceutical companies. He has published over 55 peer-reviewed publications in leading pharmacology journals, and has presented nationally and internationally in a variety of different venues. Dr. Bilsky is a co-founder of a small biotechnology company (Aiko Pharmaceuticals) that is developing a unique class of opioid antagonists for the management of opioid-mediated side effects. He also serves as a consultant for several pharmaceutical companies developing CNS-based therapeutics. He recently served as the chair of the University of New England Faculty Assembly and is an Associate Editor for the Life Sciences, a journal publishing research in the biomedical sciences.


Center for Excellence in Neurosciences


4:00 PM
Hannaford Lecture Hall, College of Pharmacy

Portland Campus

Free and open to the public